LEP and obesity due to melanocortin 4 receptor deficiency: Therapeutic interventions aimed at restoring balance by suppressing leptin in chronic inflammation, replenishing it when deficient, or normalizing downstream signaling (JAK-STAT, mTORC1) may enhance vaccine responsiveness, reverse obesity-associated immunocompromise, and restore B cell tolerance in autoimmunity.